Drugs / BHV-700
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07125261 | Oct 2025 → Mar 2026 overdue | epilepsy | Yale University | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BHV-700 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07125261 ↗ |
| Action | Activate | “potassium channel activator” NCT07125261 ↗ |